Mutations in UBQLN2 Cause Dominant X-linked Juvenile and Adult-Onset ALS and ALS/dementia

Han-Xiang Deng,Wenjie Chen,Seong-Tshool Hong,Kym M. Boycott,George H. Gorrie,Nailah Siddique,Yi Yang,Faisal Fecto,Yong Shi,Hong Zhai,Hujun Jiang,Makito Hirano,Evadnie Rampersaud,Gerard H. Jansen,Sandra Donkervoort,Eileen H. Bigio,Benjamin R. Brooks,Kaouther Ajroud,Robert L. Sufit,Jonathan L. Haines,Enrico Mugnaini,Margaret A. Pericak-Vance,Teepu Siddique
DOI: https://doi.org/10.1038/nature10353
IF: 64.8
2011-01-01
Nature
Abstract:Ubiquilin 2 pathology in ALS and ALS/dementia A study of a five-generation family with the usually fatal disorder amyotrophic lateral sclerosis (ALS) has identified mutations in the UBQLN2 gene, which encodes the ubiquitin-like protein ubiquilin 2, as a cause of ALS and ALS/dementia. This finding is of particular interest as it links familial and sporadic forms of the disease through a ubiquilin 2 pathology observed in the spinal cords of ALS cases and in the brains of ALS/dementia cases with or without UBQLN2 mutations. This novel pathology shows that abnormalities in ubiquilin 2 are associated with defects in the protein degradation pathway, abnormal protein aggregation and neurodegeneration, indicating a common pathogenic mechanism that might be a target for therapeutic intervention.
What problem does this paper attempt to address?